These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 2372742)

  • 1. Impairment of human antipyrine metabolism by piroxicam.
    Battellino LJ; Dorronsoro de Cattoni ST; Ragagnin C
    Can J Physiol Pharmacol; 1990 Jun; 68(6):711-7. PubMed ID: 2372742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of repeated oral doses of lornoxicam on antipyrine elimination in normal human volunteers.
    Ravic M; Johnston A; Turner P; Takacs F; Rosenow DE
    Hum Exp Toxicol; 1991 Sep; 10(5):375-7. PubMed ID: 1683552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitory effect of isoniazid on antipyrine clearance in man.
    Grech-Belanger O; Belanger PM; Lachance J
    J Clin Pharmacol; 1983; 23(11-12):540-4. PubMed ID: 6662978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparative study of antipyrine pharmacokinetics in saliva and plasma using a colourimetric method of antipyrine analysis.
    Harman AE; Priestly BG; Frewin DB
    Clin Exp Pharmacol Physiol; 1977; 4(6):593-6. PubMed ID: 589875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Salivary antipyrine kinetics in hepatic and renal disease and in patients on anticonvulsant therapy.
    Harman AW; Penhall RK; Priestly BG; Frewin DB; Phillips PJ; Clarkson AR
    Aust N Z J Med; 1977 Aug; 7(4):385-90. PubMed ID: 270989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antipyrine elimination in saliva after low-dose combined or progestogen-only oral contraceptive steroids.
    Chambers DM; Jefferson GC; Chambers M; Loudon NB
    Br J Clin Pharmacol; 1982 Feb; 13(2):229-32. PubMed ID: 7059420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of ticlopidine during chronic oral administration to healthy volunteers and its effects on antipyrine pharmacokinetics.
    Knudsen JB; Bastain W; Sefton CM; Allen JG; Dickinson JP
    Xenobiotica; 1992 May; 22(5):579-89. PubMed ID: 1413873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of fenfluramine on disposition and rate of antipyrine elimination.
    O'Malley K; Stevenson IH; West M
    Pharmacology; 1975; 13(1):12-9. PubMed ID: 1153500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on theophylline metabolism: autoinduction and inhibition by antipyrine.
    Denlinger CL; Stryker KK; Slusher LB; Vesell ES
    Clin Pharmacol Ther; 1987 May; 41(5):522-30. PubMed ID: 3568537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elimination of antipyrine from saliva as a measure of metabolism in man.
    Welch RM; DeAngelis RL; Wingfield M; Farmer TW
    Clin Pharmacol Ther; 1975 Sep; 18(3):249-58. PubMed ID: 1164815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction between antipyrine and aminopyrine.
    Vesell ES; Passananti GT; Hepner GW
    Clin Pharmacol Ther; 1976 Dec; 20(6):661-9. PubMed ID: 991537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Saliva and plasma clearance of antipyrine as reflectors of liver function.
    Luoma PV; Sotaniemi EA
    Eur J Drug Metab Pharmacokinet; 1981; 6(4):261-4. PubMed ID: 7333326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of etiocholanolone-induced fever on plasma antipyrine half-lives and metabolic clearance.
    Elin RJ; Vesell ES; Wolff SM
    Clin Pharmacol Ther; 1975 Apr; 17(4):447-57. PubMed ID: 1122686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Oxidative hepatic metabolism in chronic alcoholics during the acute abstinence period: evaluation with antipyrine elimination].
    Soto Alvarez J; Alsar Ortiz MJ
    Rev Clin Esp; 1993 Jun; 193(2):60-3. PubMed ID: 8341815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antipyrine metabolism in patients with diabetes mellitus.
    Murali KV; Adithan C; Shashindran CH; Gambhir SS; Chandrasekar S
    Clin Exp Pharmacol Physiol; 1983; 10(1):7-13. PubMed ID: 6839551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of age and sex on metabolism and urinary excretion of antipyrine.
    Jorquera F; Almar M; Pozuelo M; Sansegundo D; González-Sastre M; González-Gallego J
    J Gerontol A Biol Sci Med Sci; 1998 Jan; 53(1):M14-9. PubMed ID: 9467428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A pilot study of the effect of antipyrine on caffeine kinetics in six healthy volunteer subjects.
    Soto J; Alsar MJ
    J Clin Pharm Ther; 1997 Jun; 22(3):191-5. PubMed ID: 9447474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of amiodarone and desethylamiodarone on the pharmacokinetics of antipyrine in the rat.
    Svensson CK; Liu LL; Knowlton PW
    Pharm Res; 1987 Jun; 4(3):251-4. PubMed ID: 3509291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dextromethorphan pretreatment induces antipyrine clearance in the rat.
    Svensson CK; Ware JA
    Pharm Res; 1988 Jul; 5(7):437-9. PubMed ID: 3247313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of prolonged oral cimetidine, ranitidine, and famotidine therapy on antipyrine elimination.
    Sakaue H; Akamatsu K; Hirabayashi Y; Sasaki T; Nakanishi K; Okada S; Kanaoka M; Nishinobu M; Masumoto S; Ohta Y
    Clin Ther; 1987; 9(6):602-6. PubMed ID: 2894244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.